These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23575354)

  • 1. Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
    Kalincik T; Guttmann CR; Krasensky J; Vaneckova M; Lelkova P; Tyblova M; Seidl Z; De Jager PL; Havrdova E; Horakova D
    Genes Immun; 2013 Jun; 14(4):244-8. PubMed ID: 23575354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
    van Pelt ED; Mescheriakova JY; Makhani N; Ketelslegers IA; Neuteboom RF; Kundu S; Broer L; Janssens C; Catsman-Berrevoets CE; van Duijn CM; Banwell B; Bar-Or A; Hintzen RQ
    Neurology; 2013 Dec; 81(23):1996-2001. PubMed ID: 24198294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis.
    Sombekke MH; Arteta D; van de Wiel MA; Crusius JB; Tejedor D; Killestein J; Martínez A; Peña AS; Polman CH; Uitdehaag BM
    Mult Scler; 2010 Jun; 16(6):652-9. PubMed ID: 20378664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
    Strijbis EM; Inkster B; Vounou M; Naegelin Y; Kappos L; Radue EW; Matthews PM; Uitdehaag BM; Barkhof F; Polman CH; Montana G; Geurts JJ
    Mult Scler; 2013 Mar; 19(3):281-8. PubMed ID: 22851457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis.
    Schrijver HM; Hooper-van Veen T; van Belzen MJ; Crusius JB; Peña AS; Barkhof F; Polman CH; Uitdehaag BM
    Eur J Immunogenet; 2004 Jun; 31(3):133-40. PubMed ID: 15182327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of magnetic resonance imaging in patients with clinically isolated syndrome conversion to multiple sclerosis: a meta-analysis.
    Zhang WY; Hou YL
    Neurol India; 2013; 61(3):231-8. PubMed ID: 23860140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
    Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
    Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalamic damage and long-term progression of disability in multiple sclerosis.
    Rocca MA; Mesaros S; Pagani E; Sormani MP; Comi G; Filippi M
    Radiology; 2010 Nov; 257(2):463-9. PubMed ID: 20724544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F; Rovaris M; Pagani E; Sormani MP; Comi G; Filippi M
    Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.